Results 271 to 280 of about 34,144 (356)

Severe Hepatic Adverse Event Induced by Anti‐HER2 Therapy in Breast Cancer: A Case of Successful Immunotherapy With Baricitinib

ACR Open Rheumatology, Volume 8, Issue 2, February 2026.
Yufei Li, Yifan Wang, Miao Shao, Jing He
wiley   +1 more source

Progression to Decompensation of Severe Fibrosis Compared to Cirrhosis in MASLD: A Systematic Review and Meta‐Analysis

Liver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background & Aims Metabolic associated steatotic liver disease (MASLD) is increasing in prevalence worldwide. Clinical practice is focused on identifying those with cirrhosis and monitoring for complications such as varices and hepatocellular carcinoma (HCC).
Rachael Barrett, Annie Archer, Jennifer Cathcart, Kushala Abeysekera, John F. Dillon, Paul N. Brennan   +5 more
wiley   +1 more source

Detection of SARS-CoV-2 in ascitic fluid: a case of viral peritonitis?

, 2020
Passarelli VC, Perosa AH, Luna L, Conte DD, Nascimento OA, Ota-Arakaki J, Bellei N.   +6 more
europepmc   +1 more source

Bacterial Infections in Cirrhosis. [PDF]

, 2013
Papp, Mária, Vitalis, Zsuzsanna
core  

Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes

Advanced Functional Materials, Volume 36, Issue 1, 2 January 2026.
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth, Neal I. Callaghan, Locke Davenport Huyer   +2 more
wiley   +1 more source

Measurement of Adenosine Deaminase in Ascitic Fluid Contributed to the Diagnosis in a Case of Tuberculous Peritonitis. [PDF]

Case Rep Gastroenterol, 2019
Kishimoto K, Mishiro T, Mikami H, Yamashita N, Hara K, Hamamoto W, Cho Y, Ikuta Y, Nagasaki M, Kinoshita Y.   +9 more
europepmc   +1 more source

In Vivo Efficacy of Zinc Phthalocyanine Nanocarriers IN Photodynamic Therapy of Cancer

Advanced Therapeutics, Volume 9, Issue 1, January 2026.
Zinc phthalocyanines are photosensitizing agents used in photodynamic therapy. Their incorporation into nanosystems enables their encapsulation, targeting, and functionalization, optimizing their therapeutic activity. The results highlight their therapeutic potential, reinforcing their relevance as an innovative strategy in cancer treatment and as a ...
Adrian Lima Roberto, Kammila Martins Nicolau Costa, Sara Efigênia Dantas de Mendonça y Araújo, Ingrid Larissa da Silva Soares, João Augusto Oshiro‐Junior   +4 more
wiley   +1 more source

Mean platelet volume is a useful indicator of systemic inflammation in cirrhotic patients with ascitic fluid infection

, 2014
Burak Suvak, Serkan Torun, Adnan Taş, Yavuz Beyazıt   +3 more
openalex   +1 more source

Puerarin Targets MIC19 to Suppress Mitochondrial Metabolism of Tumor‐Infiltrating Tregs and Enhance Anti‐tumor Immunity

Advanced Science, Volume 13, Issue 4, 19 January 2026.
Puerarin targets mitochondrial MIC19 in tumor‐infiltrating Tregs, impairing their immunosuppressive function and enhancing antitumor immunity. This study uncovers the metabolic dependency of tumor‐infiltrating Tregs and highlights a potential metabolic‐targeted immunotherapeutic strategy for liver cancer. Abstract Regulatory T cells (Tregs) are pivotal
Yu Li, Ziyan Song, Jianjun Ding, Yiheng Zhou, Tianning Huang, Qufei Qian, Miao Yu, Wenzhao Chen, Jiazheng Liu, Ling Lu, Qiuyang Chen   +10 more
wiley   +1 more source

Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites. [PDF]

United European Gastroenterol J, 2019
Simbrunner B, Röthenbacher A, Haslacher H, Bauer D, Chromy D, Bucsics T, Schwabl P, Paternostro R, Scheiner B, Trauner M, Mandorfer M, Schwarzinger I, Reiberger T.   +12 more
europepmc   +1 more source